PDF herunterladen
Dialyse aktuell 2019; 23(09): 404-410
DOI: 10.1055/a-0969-0477
Schwerpunkt | Dialyse
© Georg Thieme Verlag Stuttgart · New York

Verminderung des kardiovaskulären Risikos an der Hämo- und Peritonealdialyse

Wie groß ist der Einfluss der Ernährung?
Matthias C. Braunisch
1   Abteilung für Nephrologie, Klinikum rechts der Isar, Fakultät für Medizin, Technische Universität München
,
Barbara Contzen
2   Ernährungswerkstatt Barbara Contzen, Bergisch Gladbach
,
Claudius Küchle
1   Abteilung für Nephrologie, Klinikum rechts der Isar, Fakultät für Medizin, Technische Universität München
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
20. November 2019 (online)

Auch verfügbar auf
    Lizenzen und Reprints

ZUSAMMENFASSUNG

Dialysepatienten leiden in hohem Maße unter einer erhöhten kardiovaskulären Morbidität und Mortalität, die auch durch ernährungsbedingte Faktoren wie z. B. Hyperphosphatämie verursacht werden. Gerade hier spielt die Ernährungstherapie hinsichtlich phosphatreicher Nahrungsmittel eine wichtige Rolle. In letzter Zeit ist der Zusammenhang zwischen einer zu geringen alimentären Magnesium-Zufuhr und der Gefäßverkalkung durch die Kalzium-Phosphat-Komplexierung in den Fokus geraten. Hier wäre eine alimentäre Zufuhr wünschenswert, ist aber beim Dialysepatienten nur schwer durchführbar, da magnesiumreiche Nahrungsmittel meist auch kaliumreich sind. Ähnliches gilt für die mediterrane Kost, welche in der Allgemeinbevölkerung zur kardiovaskulären Risikoreduktion beiträgt. Beim Dialysepatienten konnte bisher jedoch nur der Nutzen von gesteigerter Obst- und Gemüsezufuhr hinsichtlich einer Mortalitätsreduktion nachgewiesen werden.

 

  • Literatur

  • 1 Goodman WG, Goldin J, Kuizon BD. et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. New Engl J Med 2000; 342: 1478-1483 doi:10.1056/nejm200005183422003
    CrossrefPubMedSuche in Google Scholar
  • 2 Fellström BC, Jardine AG, Schmieder RE. et al. Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis. New Engl J Med 2009; 360: 1395-1407 doi:10.1056/NEJMoa0810177
    CrossrefPubMedSuche in Google Scholar
  • 3 Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890-897 doi:10.1038/ki.2008.644
    CrossrefPubMedSuche in Google Scholar
  • 4 Khor BH, Narayanan SS, Sahathevan S. et al. Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis. Nutrients 2018; 10 pii: E397 doi:10.3390/nu10040397
    CrossrefPubMedSuche in Google Scholar
  • 5 Tennankore KK, Bargman JM. Nutrition and the kidney: recommendations for peritoneal dialysis. Adv Chronic Kidney Dis 2013; 20: 190-201 doi:10.1053/j.ackd.2012.10.010
    CrossrefPubMedSuche in Google Scholar
  • 6 Stenvinkel P, Carrero JJ, Axelsson J. et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. Clin J Am Soc Nephrol 2008; 3: 505-521 doi:10.2215/cjn.03670807
    CrossrefPubMedSuche in Google Scholar
  • 7 Kopple JD. National kidney foundation K/DOQI cl inical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2001; 37 (Suppl. 02) S66-S70 doi:10.1053/ajkd.2001.20748
    CrossrefPubMedSuche in Google Scholar
  • 8 Shroff RC, McNair R, Skepper JN. et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010; 21: 103-112 doi:10.1681/asn.2009060640
    CrossrefPubMedSuche in Google Scholar
  • 9 Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002; 15: 329-337
    CrossrefPubMedSuche in Google Scholar
  • 10 Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115-126 doi:10.1056/nejm199901143400207
    CrossrefPubMedSuche in Google Scholar
  • 11 Markell MS, Altura BT, Sarn Y, Delano BG, Ifudu O, Friedman EA, Altura BM. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis. ASAIO J 1992; 39: M801-M804
    Suche in Google Scholar
  • 12 Ishimura E, Okuno S, Yamakawa T. et al. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 2007; 20: 237-244
    PubMedSuche in Google Scholar
  • 13 Lacson Jr E, Wang W, Ma L, Passlick-Deetjen J. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study. Am J Kidney Dis 2015; 66: 1056-1066 doi:10.1053/j.ajkd.2015.06.014
    CrossrefPubMedSuche in Google Scholar
  • 14 de Roij van Zuijdewijn CL, Grooteman MP. et al. Serum Magnesium and Sudden Death in European Hemodialysis Patients. PLoS One 2015; 10: e0143104 doi:10.1371/journal.pone.0143104
    CrossrefPubMedSuche in Google Scholar
  • 15 Sakaguchi Y, Fujii N, Shoji T. et al. Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study. PLoS One 2014; 9: e116273 doi:10.1371/journal.pone.0116273
    CrossrefPubMedSuche in Google Scholar
  • 16 Joao Matias P, Azevedo A, Laranjinha I. et al. Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients. Blood Purif 2014; 38: 244-252 doi:10.1159/000366124
    CrossrefPubMedSuche in Google Scholar
  • 17 Reffelmann T, Ittermann T, Dorr M. et al. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis 2011; 219: 280-284 doi:10.1016/j.atherosclerosis.2011.05.038
    CrossrefPubMedSuche in Google Scholar
  • 18 Montezano AC, Zimmerman D, Yusuf H. et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 2010; 56: 453-462 doi:10.1161/hypertensionaha.110.152058
    CrossrefPubMedSuche in Google Scholar
  • 19 Pasch A, Farese S, Gräber S. et al. Nanoparticle-Based Test Measures Overall Propensity for Calcification in Serum. J Am Soc Nephrol 2012; 23: 1744-1752 doi:10.1681/ASN.2012030240
    CrossrefPubMedSuche in Google Scholar
  • 20 Smith ER, Ford ML, Tomlinson LA. et al. Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 2014; 25: 339-348 doi:10.1681/asn.2013060635
    CrossrefPubMedSuche in Google Scholar
  • 21 Lorenz G, Steubl D, Kemmner S. et al. Worsening calcification propensity precedes all-cause and cardiovascular mortality in haemodialyzed patients. Sci Rep 2017; 7: 13368 doi:10.1038/s41598-017-12859-6
    CrossrefPubMedSuche in Google Scholar
  • 22 Van Laecke S, Van Biesen W, Vanholder R. Hypomagnesaemia, the kidney and the vessels. Nephrol Dial Transplant 2012; 27: 4003-4010 doi:10.1093/ndt/gfs126
    CrossrefPubMedSuche in Google Scholar
  • 23 Huijgen HJ, van Ingen HE, Kok WT, Sanders GT. Magnesium fractions in serum of healthy individuals and CAPD patients, measured by an ion-selective electrode and ultrafiltration. Clin Biochem 1996; 29: 261-266 doi:10.1016/0009-9120(96)84729-b
    CrossrefPubMedSuche in Google Scholar
  • 24 Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J 2012; 5 (Suppl. 01) i3-i14 doi:10.1093/ndtplus/sfr163
    CrossrefPubMedSuche in Google Scholar
  • 25 Küchle C, Heemann U. Die Rolle von Magnesium im Kalzium-Phosphat-Haushalt. Der Nephrologe 2012; 7: 121-129 doi:10.1007/s11560-011-0593-8
    CrossrefSuche in Google Scholar
  • 26 Schmaderer C, Braunisch MC, Suttmann Y, Lorenz G, Pham D, Haller B, Angermann S, Matschkal J, Renders L, Baumann M, Braun JR, Heemann U, Kuchle C. Reduced Mortality in Maintenance Haemodialysis Patients on High versus Low Dialysate Magnesium: A Pilot Study. Nutrients 2017; 9 pii: E926 doi:10.3390/nu9090926
    CrossrefPubMedSuche in Google Scholar
  • 27 Cai K, Luo Q, Dai Z. et al. Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients. PLoS One 2016; 11: e0152488 doi:10.1371/journal.pone.0152488
    CrossrefPubMedSuche in Google Scholar
  • 28 Noordzij M, Korevaar JC, Bos WJ. et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant 2006; 21: 2513-2520 doi:10.1093/ndt/gfl257
    CrossrefPubMedSuche in Google Scholar
  • 29 Moe SM, Zidehsarai MP, Chambers MA. et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 257-264 doi:10.2215/cjn.05040610
    CrossrefPubMedSuche in Google Scholar
  • 30 Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007; 20: 295-301 doi:10.1111/j.1525-139X.2007.00309.x
    CrossrefPubMedSuche in Google Scholar
  • 31 Ritz E, Hahn K, Ketteler M. et al. Phosphate additives in food--a health risk. Dtsch Arztebl Int 2012; 109: 49-55 doi:10.3238/arztebl.2012.0049
    PubMedSuche in Google Scholar
  • 32 Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol 2009; 4: 1370-1373 doi:10.2215/cjn.02830409
    CrossrefPubMedSuche in Google Scholar
  • 33 Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology?. Semin Dial 2003; 16: 186-188
    CrossrefPubMedSuche in Google Scholar
  • 34 Gutierrez OM. Contextual poverty, nutrition, and chronic kidney disease. Adv Chronic Kidney Dis 2015; 22: 31-38 doi:10.1053/j.ackd.2014.05.005
    CrossrefPubMedSuche in Google Scholar
  • 35 Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 620-629 doi:10.2215/cjn.04620510
    CrossrefPubMedSuche in Google Scholar
  • 36 Wyskida K, Witkowicz J, Chudek J, Wiecek A. Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease. J Ren Nutr 2012; 22: 19-26 doi:10.1053/j.jrn.2011.03.001
    CrossrefPubMedSuche in Google Scholar
  • 37 Küchle C, Suttmann Y, Reichelt AL, Apfelböck J, Zoller V, Heemann U. Correcting low magnesia levels in hemodialysis by higher dialysate magnesium. Cogent Medicine 2017; 4: 1302544 doi:10.1080/2331205X.2017.1302544
    CrossrefSuche in Google Scholar
  • 38 Kuhlmann MK. Management of hyperphosphatemia. Hemodial Int 2006; 10: 338-345 doi:10.1111/j.1542-4758.2006.00126.x
    CrossrefPubMedSuche in Google Scholar
  • 39 Estruch R, Ros E, Salas-Salvado J. et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med 2018; 378: e34 doi:10.1056/NEJMoa1800389
    CrossrefPubMedSuche in Google Scholar
  • 40 Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995; 61 (Suppl.) 1402s-1406s doi:10.1093/ajcn/61.6.1402S
    CrossrefPubMedSuche in Google Scholar
  • 41 Saglimbene VM, Wong G, Craig JC. et al. The Association of Mediterranean and DASH Diets with Mortality in Adults on Hemodialysis: The DIET-HD Multinational Cohort Study. J Am Soc Nephrol 2018; 29: 1741-1751 doi:10.1681/asn.2018010008
    CrossrefPubMedSuche in Google Scholar
  • 42 Saglimbene VM, Wong G, Ruospo M. et al. Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis. Clin J Am Soc Nephrol 2019; 14: 250-260 doi:10.2215/cjn.08580718
    CrossrefPubMedSuche in Google Scholar
  • 43 Moorthi RN. Does an Apple (or Many) Each Day, Keep Mortality Away?. Clin J Am Soc Nephrol 2019; 14: 180-181 doi:10.2215/cjn.15001218
    CrossrefPubMedSuche in Google Scholar
  • 44 St-Jules DE, Goldfarb DS, Sevick MA. Nutrient Non-equivalence: Does Restricting High-Potassium Plant Foods Help to Prevent Hyperkalemia in Hemodialysis Patients?. J Ren Nutr 2016; 26: 282-287 doi:10.1053/j.jrn.2016.02.005
    CrossrefPubMedSuche in Google Scholar
  • 45 Chauveau P, Aparicio M, Bellizzi V. et al. Mediterranean diet as the diet of choice for patients with chronic kidney disease. Nephrol Dial Transplant 2018; 33: 725-735 doi:10.1093/ndt/gfx085
    CrossrefPubMedSuche in Google Scholar
  • 46 Kuhlmann MK. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif 2010; 29: 137-144 doi:10.1159/000245640
    CrossrefPubMedSuche in Google Scholar
  • 47 Fein P, Weiss S, Ramos F. et al. Serum magnesium concentration is a significant predictor of mortality in peritoneal dialysis patients. Adv Perit Dial 2014; 30: 90-93
    PubMedSuche in Google Scholar
  • 48 Ahlenstiel T, Pape L, Ehrich JH, Kuhlmann MK. Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease. Nephrol Dial Transplant 2010; 25: 3241-3249 doi:10.1093/ndt/gfq161
    CrossrefPubMedSuche in Google Scholar
  • 49 Contzen B, modifiziert nach: Heseker H, Heseker B. Deutsche Gesellschaft für Ernährung e. V. Die Nährwerttabelle. 2. Aufl. Neustadt an der Weinstraße: Neuer Umschau Buchverlag GmbH 2012
    PubMedSuche in Google Scholar